Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition - Concepedia

Concepedia

Publication | Open Access

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

DOI Full Paper Access

80

Citations

57

References

2015

Year

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou, Evangelia D. Chrysina, Jérémy Leroy, Sophie Balzarin, Michel Tournier, Didier Tousch, Pierre Petit, Cédric Duret,

European Journal of Medicinal Chemistry

Glucose-derived Spiro-isoxazolinesMetabolic SyndromeDiabetes ManagementBiochemistryGlycogen Phosphorylase InhibitionMedicineDiabetesType 2Diabetes MellitusInsulin DeliveryPharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1